FDA inspection
Neopharm Labs Inc.: FDA inspection ending May 1, 2012
FDA inspection 783959 · No Action Indicated (NAI) · Blainville
Key facts
| Inspection ID | 783959 |
|---|---|
| Firm | Neopharm Labs Inc. |
| FEI number | 3002807703 |
| Address | 865 Michele-Bohec Blvd |
| City | Blainville |
| Country | Canada |
| Fiscal year | 2012 |
| Inspection end date | May 1, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data